Dabigatran vs Trastuzumab

Dabigatran vs Trastuzumab: Overview

This comparison examines the pharmacological differences between Dabigatran and Trastuzumab.

Mechanism of Action

Dabigatran: Direct thrombin (Factor IIa) inhibitor.

Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

Pharmacokinetics

Half-life: Dabigatran — 12-17 hours; Trastuzumab — 28 days.

Chemical Properties

Molecular Formula: Dabigatran — C25H25N7O3.

Molecular Weight: Dabigatran — 471.5100 g/mol.

Type: Dabigatran — Small molecule; Trastuzumab — Antibody.